JP2002519340A5 - - Google Patents

Download PDF

Info

Publication number
JP2002519340A5
JP2002519340A5 JP2000557229A JP2000557229A JP2002519340A5 JP 2002519340 A5 JP2002519340 A5 JP 2002519340A5 JP 2000557229 A JP2000557229 A JP 2000557229A JP 2000557229 A JP2000557229 A JP 2000557229A JP 2002519340 A5 JP2002519340 A5 JP 2002519340A5
Authority
JP
Japan
Prior art keywords
compound
mmol
formula
preparation
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000557229A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002519340A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/014627 external-priority patent/WO2000000468A1/en
Publication of JP2002519340A publication Critical patent/JP2002519340A/ja
Publication of JP2002519340A5 publication Critical patent/JP2002519340A5/ja
Withdrawn legal-status Critical Current

Links

JP2000557229A 1998-06-30 1999-06-28 甲状腺ホルモン類似体およびそれらの調製方法 Withdrawn JP2002519340A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9118598P 1998-06-30 1998-06-30
US60/091,185 1998-06-30
PCT/US1999/014627 WO2000000468A1 (en) 1998-06-30 1999-06-28 Thyroid hormone analogues and methods for their preparation

Publications (2)

Publication Number Publication Date
JP2002519340A JP2002519340A (ja) 2002-07-02
JP2002519340A5 true JP2002519340A5 (https=) 2006-08-31

Family

ID=22226506

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000557229A Withdrawn JP2002519340A (ja) 1998-06-30 1999-06-28 甲状腺ホルモン類似体およびそれらの調製方法

Country Status (13)

Country Link
US (1) US6107517A (https=)
EP (2) EP1089968B1 (https=)
JP (1) JP2002519340A (https=)
KR (1) KR20010053277A (https=)
AT (1) ATE293595T1 (https=)
AU (1) AU4840199A (https=)
CA (1) CA2335551C (https=)
DE (1) DE69924846T2 (https=)
DK (1) DK1089968T3 (https=)
ES (1) ES2241294T3 (https=)
IL (1) IL140140A0 (https=)
PT (1) PT1089968E (https=)
WO (1) WO2000000468A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883294A (en) * 1997-06-18 1999-03-16 The Regeants Of The University Of California Selective thyroid hormone analogs
AU3507800A (en) * 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Method of treating hair loss using diphenylmethane derivatives
WO2000072810A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
EP1351671A1 (en) * 2001-01-19 2003-10-15 Cytokinetics, Inc. Triphenylmethane kinesin inhibitors
US7302347B2 (en) * 2002-12-10 2007-11-27 The Regents Of The University Of California Method for creating specific, high affinity nuclear receptor pharmaceuticals
SE526033C3 (sv) * 2003-11-06 2009-12-08 Metso Paper Inc Silanordning och silkorg för silning av massasuspensioner
CN1882327A (zh) 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
MX2007014502A (es) 2005-05-26 2008-02-07 Metabasis Therapeutics Inc Tiromimeticos para el tratamiento de enfermedades del higado graso.
WO2006128056A2 (en) * 2005-05-26 2006-11-30 Metabasis Therapeutics, Inc. Novel phosphinic acid-containing thyromimetics
WO2007002036A1 (en) * 2005-06-24 2007-01-04 Thomas Lavin Tyroid hormone in burn and adipose deposites
WO2014178892A1 (en) 2013-05-03 2014-11-06 Scanlan Thomas S Use of sobetirome in the treatment of x-linked adrenolenoleukodystrophy
DK3457851T3 (da) * 2016-05-18 2021-09-20 Univ Oregon Health & Science Derivater af sobetirom
JP2020500199A (ja) 2016-11-21 2020-01-09 バイキング・セラピューティクス・インコーポレイテッド グリコーゲン蓄積症の治療方法
AU2018280118B2 (en) 2017-06-05 2021-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
ES3053674T3 (en) 2018-03-22 2026-01-23 Viking Therapeutics Inc Crystalline forms and methods of producing crystalline forms of a compound
WO2020117962A1 (en) 2018-12-05 2020-06-11 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation
AU2019397067A1 (en) 2018-12-12 2021-07-22 Autobahn Therapeutics, Inc. Novel thyromimetics
WO2020180624A1 (en) 2019-03-01 2020-09-10 Autobahn Therapeutics, Inc. Novel thyromimetics
US12466781B2 (en) 2019-11-29 2025-11-11 Autobahn Therapeutics, Inc. Thyromimetics
WO2021257851A1 (en) 2020-06-17 2021-12-23 Autobahn Therapeutics, Inc. Thyromimetics
US12590072B2 (en) 2020-06-17 2026-03-31 Autobahn Therapeutics, Inc. Thyromimetics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3332957A (en) * 1964-09-02 1967-07-25 Ciba Geigy Corp Amino esters of substituted phenoxy acetic acids
JPS5195049A (en) * 1975-02-12 1976-08-20 * **********so*****no***tsu*****************************************ni*no
US4323691A (en) * 1979-10-09 1982-04-06 Abbott Laboratories Hydroxyaminomethyl derivatives of benzoyl di-substituted α-phenoxyalkanoyl esters
US5883294A (en) * 1997-06-18 1999-03-16 The Regeants Of The University Of California Selective thyroid hormone analogs

Similar Documents

Publication Publication Date Title
JP2002519340A5 (https=)
EP1089968B1 (en) Thyroid hormone analogues and methods for their preparation
EP0463945A1 (fr) Nouvelles chalcones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0540400B1 (fr) Dérivés de quinoléine, utile comme angiotensine II antagonistes
JP2583545B2 (ja) α−ハロゲン化ジカルボン酸誘導体、その製法及び該化合物を含有する脂肪症、高脂質血症又は糖尿病用薬
EP0196943B1 (fr) Nouveaux dérivés 8-thiotétrahydroquinoléines et leurs sels
EP0599697A1 (fr) Dérivés de pyrrole, leur préparation et leur application en thérapeutique
EP0337885B1 (fr) Nouveaux dérivés triéniques de structure chroménique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
EP3592753B1 (fr) Nouvelle composition d'isomeres du 7,9-dodécadiényl-1-acétate et son procede de fabrication
EP0650953B1 (fr) Analogues cyclisés de métabolites d'acides gras, leur procédé de préparation et les compositions pharmaceutiques les renfermant
EP1242381A2 (fr) Derives de 2-phenyl-quinoleine et leur utilisation en tant qu'agent contractant des muscles lisses
BE1001109A3 (fr) Nouvelles prostacyclines.
FR2693197A1 (fr) Nouveaux dérivés de quinoléine, leur procédé de préparation et leur application thérapeutique.
CH641188A5 (fr) Arylalkyl- et aryloxyalkyl- phosphonates, leur preparation et composition therapeutique les contenant.
EP1131293A1 (fr) Derives de 1-aminoethylquinoleine pour le traitement de l'incontinence urinaire
JP2004224899A (ja) 抗酸化剤
FR2698364A1 (fr) Dérivés de pyrrole, leur préparation et leur application en thérapeutique.
EP0288647A1 (fr) Dérivés du [(pyrrolidinyl-1)-2éthoxy]-5 p-cymène, le procédé de préparation desdits dérivés et les médicaments contenant lesdits dérivés
EP0143018A1 (fr) Procédé de préparation de quinolinones-4
EP0604259A1 (fr) Dérivés de 3-(quinoléin-6-yl-méthyl)-4H-imidazol-4-one comme angiotensin II antagonistes
EP1240146A1 (fr) Derives de 2-arylquinoleine, leur preparation et leur application en therapeutique
EP0172066A1 (fr) Procédé de préparation de composés halogénés en alpha d'un groupement électro-attracteur
CH653686A5 (fr) Aminoacides isomeres, leur preparation et compositions pharmaceutiques les contenant.
FR2552430A1 (fr) Procede de preparation de quinolinones-4
FR2570700A2 (fr) Derives de pyrrolo-indole, leur preparation et leur application en therapeutique